Riot control agents: The tear gases CN, CS and OC-a medical review

Journal of the Royal Army Medical Corps

Volumn 161, Issue 2, 2015, Pages 94-99

  Schep, Leo J ^a   Slaughter, R J ^a   McBride, D I ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLOROBENZYLIDENEMALONONITRILE; OLEORESINS; PHENACYL CHLORIDE; PLANT EXTRACT; RIOT CONTROL AGENT;

CIVIL DISORDER; HUMAN; MILITARY MEDICINE; PREVENTION AND CONTROL; PROTECTIVE EQUIPMENT; SOLDIER;

HUMANS; MILITARY MEDICINE; MILITARY PERSONNEL; O-CHLOROBENZYLIDENEMALONITRILE; OMEGA-CHLOROACETOPHENONE; PLANT EXTRACTS; PROTECTIVE DEVICES; RIOT CONTROL AGENTS, CHEMICAL; RIOTS;

EID: 84988624745     PISSN: 00358665     EISSN: None     Source Type: Journal    
DOI: 10.1136/jramc-2013-000165     Document Type: Review

References (96)

1. Blain PG. Tear gases and irritant incapacitants. 1-chloroacetophenone, 2-chlorobenzylidene malononitrile and dibenz[b,f]-1,4-oxazepine. Toxicol Rev 2003;22:103–10.
2. Carron PN, Yersin B. Management of the effects of exposure to tear gas. BMJ 2009;338:b2283.
3. Fraunfelder FT. Is CS gas dangerous? Current evidence suggests not but unanswered questions remain. BMJ 2000;320:458–9.
4. Thomas RJ, Smith PA, Rascona DA, et al. Acute pulmonary effects from o-chlorobenzylidenemalonitrile “tear gas”: a unique exposure outcome unmasked by strenuous exercise after a military training event. Mil Med 2002;167:136–9.
5. Beswick FW. Chemical agents used in riot control and warfare. Hum Toxicol 1983;2:247–56.
6. Hu H, Fine J, Epstein P, et al. Tear gas—harassing agent or toxic chemical weapon? JAMA 1989;262:660–3.
7. Convention on the Prohibition of the Development, Production, Stockpiling and Use of Chemical Weapons and on their Destruction; Geneva: United Nations, 1992. http://www.opcw.org/about-chemical-weapons/types-of-chemical-agent/riot-controlagents/ (accessed 7 Nov 2013).
8. Risen J. 2005 Use of gas by Blackwater leaves questions. New York Times. 2008 10 Jan 2008. http://www.nytimes.com/2008/01/10/world/middleeast/10blackwater.html?pagewanted=all&_r=0 (accessed 17 Feb 2013).
9. Olajos EJ, Salem H. Riot control agents: pharmacology, toxicology, biochemistry and chemistry. J Appl Toxicol 2001;21:355–91.
10. O’Neil M. ed. The Merck index. 14th edn. Whitehouse Station, NJ: Merck & Co, 2006.
11. Jacobs MB. War gases, their identification and decontamination. New York: Interscience Publishers, Inc, 1942.
12. Corson BB. Reactions of alpha, beta-unsaturated dinitriles. J Am Chem Soc 1928;50:2825–37.
13. Hayman M, Kam PCA. Capsaicin: a review of its pharmacology and clinical applications. Curr Anaesth Crit Care 2008;19:338–43.
14. Ballantyne B. Medical management of the traumatic consequences of civil unrest incidents: causation, clinical approaches, needs and advanced planning criteria. Toxicol Rev 2006;25:155–97.
15. Gray PJ. Is CS spray dangerous. Formulation affects toxicity. BMJ 2000;321:46–7.
16. Holland P, White RG. The cutaneous reactions produced by o-chlorobenzylidenemalononitrile and -chloroacetophenone when applied directly to the skin of human subjects. Br J Dermatol 1972;86:150–4.
17. Sanford JP. Medical aspects of riot control (harassing) agents. Annu Rev Med 1976;27:421–9.
18. Worthington E, Nee PA. CS exposure—clinical effects and management. J Accid Emerg Med 1999;16:168–70.
19. Bessac BF, Jordt SE. Breathtaking TRP channels: TRPA1 and TRPV1 in airway chemosensation and reflex control. Physiology (Bethesda) 2008;23:360–70.
20. Cucinell SA, Swentzel KC, Biskup R, et al. Biochemical interactions and metabolic fate of riot control agents. Fed Proc 1971;30:86–91.
21. Brewster K, Harrison JM, Leadbeater L, et al. The fate of 2-chlorobenzylidene malononitrile (CS) in rats. Xenobiotica 1987;17:911–24.
22. Chapman AJ, White C. Death resulting from lacrimatory agents. J Forensic Sci 1978;23:527–30.
23. Naeve W. A fatal case of chloracetophenone poisoning (“tear gas” poisoning). Arch Toxikol 1960;18:165–9.
24. Stein AA, Kirwan WE. Chloracetophenone (tear gas) poisoning: a clinico-pathologic report. J Forensic Sci 1964;9:374–82.
25. Anonymous. “Safety” of chemical batons. Lancet 1998;352:159.
26. Oleoresin capsicum: Pepper spray as a force alternative. U.S. Department of Justice. Washington, D.C. 20531: National Institute of Justice, 1994. http://www.ncjrs.gov/pdffiles1/nij/grants/181655.pdf (accessed 7 Nov 2013).
27. Punte CL, Owens EJ, Gutentag PJ. Exposures to orthochlorobenzylidene malononitrile. Controlled human exposures. Arch Environ Health 1963;6:366–74.
28. Beswick FW, Holland P, Kemp KH. Acute effects of exposure to orthochlorobenzylidene malononitrile (CS) and the development of tolerance. Br J Ind Med 1972;29:298–306.
29. Dong C, de la Garza A. Chlorobenzylidenemalonitrile gas exposure from a novelty personal-protection gun. Cal J Emerg Med 2007;8:57–60.
30. Euripidou E, MacLehose R, Fletcher A. An investigation into the short term and medium term health impacts of personal incapacitant sprays. A follow up of patients reported to the National Poisons Information Service (London). Emerg Med J 2004;21:548–52.
31. Zekri AM, King WW, Yeung R, et al. Acute mass burns caused by o-chlorobenzylidene malononitrile (CS) tear gas. Burns 1995;21:586–9.
32. Anderson PJ, Lau GS, Taylor WR, et al. Acute effects of the potent lacrimator o-chlorobenzylidene malononitrile (CS) tear gas. Hum Exp Toxicol 1996;15:461–5.
33. Breakell A, Bodiwala GG. CS gas exposure in a crowded night club: the consequences for an accident and emergency department. J Accid Emerg Med 1998;15:56–7.
34. Bhattacharya ST, Hayward AW. CS gas—implications for the anaesthetist. Anaesthesia 1993;48:896–7.
35. Owens EJ, Punte CL. Human respiratory and ocular irritation studies utilizing o-chlorobenzylidene malononitrile aerosols. Am Ind Hyg Assoc J 1963;24:262–4.
36. Hankin SM, Ramsay CN. Investigation of accidental secondary exposure to CS agent. Clin Toxicol (Phila) 2007;45:409–11.
37. Davey A, Moppett IK. Postoperative complications after CS spray exposure. Anaesthesia 2004;59:1219–20.
38. Hu H, Christiani D. Reactive airways dysfunction after exposure to teargas. Lancet 1992;339:1535.
39. Solomon I, Kochba I, Eizenkraft E, et al. Report of accidental CS ingestion among seven patients in central Israel and review of the current literature. Arch Toxicol 2003;77:601–4.
40. Horton DK, Burgess P, Rossiter S, et al. Secondary contamination of emergency department personnel from o-chlorobenzylidene malononitrile exposure, 2002. Ann Emerg Med 2005;45:655–8.
41. Varma S, Holt PJ. Severe cutaneous reaction to CS gas. Clin Exp Dermatol 2001;26:248–50.
42. Karagama YG, Newton JR, Newbegin CJ. Short-term and long-term physical effects of exposure to CS spray. J R Soc Med 2003;96:172–4.
43. Watson K, Rycroft R. Unintended cutaneous reactions to CS spray. Contact Dermatitis 2005;53:9–13.
44. Lee BH, Knopp R, Richardson ML. Treatment of exposure to chemical personal protection agents. Ann Emerg Med 1984;13:487–8.
45. King K, Tunget CL, Turchen SG, et al. Severe contact dermatitis from chemical mace containing 1-chloroacetophenone. Cutan Ocul Toxicol 1995;14:57–62.
46. Forrester MB, Stanley SK. The epidemiology of pepper spray exposures reported in Texas in 1998–2002. Vet Hum Toxicol 2003;45:327–30.
47. Zollman TM, Bragg RM, Harrison DA. Clinical effects of oleoresin capsicum (pepper spray) on the human cornea and conjunctiva. Ophthalmology 2000;107:2186–9.
48. Gray PJ, Murray V. Treating CS gas injuries to the eye. Exposure at close range is particularly dangerous. BMJ 1995;311:871.
49. Hoffmann DH. Eye burns caused by tear gas. Br J Ophthalmol 1967;51:265–8.
50. Leopold IH, Lieberman TW. Chemical injuries of the cornea. Fed Proc 1971;30:92–5.
51. Midtbo A. Eye injury from tear gas. Acta Ophthalmol (Copenh) 1964;42:672–9.
52. Oaks LW, Dorman JE, Petty RW. Tear gas burns of the eye. Arch Ophthalmol 1960;63:698–706.
53. Brown L, Takeuchi D, Challoner K. Corneal abrasions associated with pepper spray exposure. Am J Emerg Med 2000;18:271–2.
54. Holopainen JM, Moilanen JA, Hack T, et al. Toxic carriers in pepper sprays may cause corneal erosion. Toxicol Appl Pharmacol 2003;186:155–62.
55. Thorburn KM. Injuries after use of the lacrimatory agent chloroacetophenone in a confined space. Arch Environ Health 1982;37:182–6.
56. Park S, Giammona ST. Toxic effects of tear gas on an infant following prolonged exposure. Am J Dis Child 1972;123:245–6.
57. Collier JG, Fuller RW. Capsaicin inhalation in man and the effects of sodium cromoglycate. Br J Pharmacol 1984;81:113–17.
58. Maxwell DL, Fuller RW, Dixon CM. Ventilatory effects of inhaled capsaicin in man. Eur J Clin Pharmacol 1987;31:715–17.
59. Queen FB, Sander T. Allergic dermatitis following exposure to tear gas (chloracetophenone, cn). JAMA 1941;117:1879.
60. Krapf R, Thalmann H. Acute exposure to CS tear gas and clinical studies. Schweiz Med Wochenschr 1981;111:2056–60.
61. Vaca FE, Myers JH, Langdorf M. Delayed pulmonary edema and bronchospasm after accidental lacrimator exposure. Am J Emerg Med 1996;14:402–5.
62. Billmire DF, Vinocur C, Ginda M, et al. Pepper-spray-induced respiratory failure treated with extracorporeal membrane oxygenation. Pediatrics 1996;98:961–3.
63. Cohle SD, Trestrail JD III, Graham MA, et al. Fatal pepper aspiration. Am J Dis Child 1988;142:633–6.
64. Hill AR, Silverberg NB, Mayorga D, et al. Medical hazards of the tear gas CS. A case of persistent, multisystem, hypersensitivity reaction and review of the literature. Medicine (Baltimore) 2000;79:234–40.
65. Shmunes E, Taylor JS. Industrial contact dermatitis. Effect of the riot control agent ortho-chlorobenzylidene malononitrile. Arch Dermatol 1973;107:212–16.
66. Suchard JR. Treatment of capsaicin (Mace?) dermatitis. Am J Emerg Med 1999;17:210–11.
67. Southward RD. Cutaneous burns from CS incapacitant spray. Med Sci Law 2001;41:74–7.
68. Agrawal Y, Thornton D, Phipps A. CS gas—completely safe? A burn case report and literature review. Burns 2009;35:895–7.
69. Parneix-Spake A, Theisen A, Roujeau JC, et al. Severe cutaneous reactions to self-defense sprays. Arch Dermatol 1993;129:913.
70. Wu K, Husain A, Barry R. Acute generalized exanthematous pustulosis induced by a topical agent: 2-chlorobenzylidene malonitrile (CS) gas. Br J Dermatol 2011;164: 227–8.
71. Hellreich A, Goldman GH, Bottiglieri NG, et al. The effects of thermally-generated CS aerosols on human skin. Edgewood, MD: Department of the Army, 1967. Edgewood Arsenal technical report 4075.
72. Frazier CA. Contact allergy to mace. JAMA 1976;236:2526.
73. Kanerva L, Tarvainen K, Pinola A, et al. A single accidental exposure may result in a chemical burn, primary sensitization and allergic contact dermatitis. Contact Dermatitis 1994;31:229–35.
74. Penneys NS, Israel RM, Indgin SM. Contact dermatitis due to 1-chloroacetophenone and chemical mace. N Engl J Med 1969;281:413–15.
75. Madden JF. Cutaneous hypersensitivity to tear gas (chloroacetophenone); a case report. AMA Arch Derm Syphilol 1951;63:133–4.
76. Holly HW, Carpenter CL. Tear gas dermatitis. JAMA 1968;203:807–8.
77. Goh CL. Allergic contact dermatitis to mace tear gas. Australas J Dermatol 1987;28:115–16.
78. Treudler R, Tebbe B, Blume-Peytavi U, et al. Occupational contact dermatitis due to 2-chloracetophenone tear gas. Br J Dermatol 1999;140:531–4.
79. Bernstein JE, Korman NJ, Bickers DR, et al. Topical capsaicin treatment of chronic postherpetic neuralgia. J Am Acad Dermatol 1989;21:265–70.
80. Williams SR, Clark RF, Dunford JV. Contact dermatitis associated with capsaicin: hunan hand syndrome. Ann Emerg Med 1995;25:713–15.
81. Sommer S, Wilkinson SM. Exposure-pattern dermatitis due to CS gas. Contact Dermatitis 1999;40:46–7.
82. Morrone A, Sacerdoti G, Franco G, et al. Tear gas dermatitis. Clin Exp Dermatol 2005;30:447–8.
83. Smith J, Greaves I. The use of chemical incapacitant sprays: a review. J Trauma 2002;52:595–600.
84. Blaho K, Winbery S. “Safety” of chemical batons. Lancet 1998;352:1633.
85. Folb PI, Talmud J. Tear gas—its toxicology and suggestions for management of its acute effects in man. S Afr Med J 1989;76:295.
86. Yih JP. CS gas injury to the eye. BMJ 1995;311:276.
87. Kiel AW. Ocular exposure to CS gas: the importance of correct early management. Eye (Lond) 1997;11(Pt 5):759–60.
88. Jones LA, Tandberg D, Troutman WG. Household treatment for “chile burns” of the hands. J Toxicol Clin Toxicol 1987;25:483–91.
89. Scott RA. Treating CS gas injuries to the eye. Illegal “Mace” contains more toxic CN particles. BMJ 1995;311:871.
90. Wiegand DA. Cutaneous reactions to the riot control agent CS. Mil Med 1969;134:182–6.
91. Winslow JE, Hill KD, Bozenman WP. Determination of optimal methods of decontamination after tear gas and pepper spray exposure [abstract]. Ann Emerg Med 2006;48:S51.
92. Viala B, Blomet J, Mathieu L, et al. Prevention of CS “tear gas” eye and skin effects and active decontamination with Diphoterine: preliminary studies in 5 French Gendarmes. J Emerg Med 2005;29:5–8.
93. Anonymous. Toxicity of CS. Lancet 1971;2:698.
94. Athanaselis S, Poulos DL, Moureinis DD, et al. Lacrimatory agents: self-defense devices or dangerous weapons? Cutan Ocul Toxicol 1990;9:3–8.
95. Snyman T, Stewart MJ, Steenkamp V. A fatal case of pepper poisoning. Forensic Sci Int 2001;124:43–6.
96. Steffee CH, Lantz PE, Flannagan LM, et al. Oleoresin capsicum (pepper) spray and “in-custody deaths”. Am J Forensic Med Pathol 1995;16:185–92.